NCT04473131View on ClinicalTrials.gov

Immune Profiling of COVID19-patients Admitted to ICU

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
COVID-19
Interventions
OTHER

No intervention

Only blood samples will be taken from participants for this study

Trial Locations (1)

Unknown

RECRUITING

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
collaborator

Qatar University

OTHER

collaborator

Weill Cornell Medical College in Qatar

OTHER

lead

Hamad Medical Corporation

INDUSTRY